Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
STAAR SURGICAL COBullish
STAAR Surgical appointed former CEO David Bailey as Chief Commercial Officer, effective September 8, 2026. His compensation package includes a $575,000 annual base salary, an initial equity grant valued at $850,000, and a 2026 long-term incentive award valued at $1,400,000.…more
STAAR SURGICAL CO
Deborah J. Andrews, an insider at STAAR SURGICAL CO, filed a Form 4 on August 18, 2026, reporting changes in beneficial ownership of securities as of August 14, 2026. This filing serves as an official disclosure of the executive's stock holdings to the SEC.…more
STAAR SURGICAL CO
Insider Warren Foust of STAAR SURGICAL CO filed a Form 4 on August 18, 2026, reporting changes in beneficial ownership of securities that occurred on August 14, 2026. This filing serves as a standard disclosure of insider equity transactions.…more
8 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
STAAR Surgical Announces New $50M Share Buyback Program
STAAR Surgical has announced the approval of a new $50 million share repurchase program. This buyback initiative is a shareholder return strategy aimed at reducing outstanding shares and potentially increasing per-share value.…more